Bispectral Index
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Remimazolam TIVA-Flumazenil Antagonism in Short-duration ENT Surgeries
Effect of Scalp Block on Bispectral Index Values During Skull Pinning
Nurse-Led BIS-Guided Sedation Protocol in Pediatric Intensive Care
BIS Monitoring in Relation to Muscle Relaxant Administration
Bispectral Index: A Comparison of Bifrontal Montage Agreement
Slow Stepwise Propofol TCI Induction for Titration Anesthesia Maintenance
Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction
Compare the Side Effects and Difference Awake Level of Three TCI Propofol Formula in TVOR Patients